clozapine-n-oxide and Pain

clozapine-n-oxide has been researched along with Pain* in 2 studies

Other Studies

2 other study(ies) available for clozapine-n-oxide and Pain

ArticleYear
Optogenetic and chemogenetic strategies for sustained inhibition of pain.
    Scientific reports, 2016, 08-03, Volume: 6

    Spatially targeted, genetically-specific strategies for sustained inhibition of nociceptors may help transform pain science and clinical management. Previous optogenetic strategies to inhibit pain have required constant illumination, and chemogenetic approaches in the periphery have not been shown to inhibit pain. Here, we show that the step-function inhibitory channelrhodopsin, SwiChR, can be used to persistently inhibit pain for long periods of time through infrequent transdermally delivered light pulses, reducing required light exposure by >98% and resolving a long-standing limitation in optogenetic inhibition. We demonstrate that the viral expression of the hM4D receptor in small-diameter primary afferent nociceptor enables chemogenetic inhibition of mechanical and thermal nociception thresholds. Finally, we develop optoPAIN, an optogenetic platform to non-invasively assess changes in pain sensitivity, and use this technique to examine pharmacological and chemogenetic inhibition of pain.

    Topics: Animals; Cells, Cultured; Channelrhodopsins; Clozapine; Combined Modality Therapy; Disease Models, Animal; Low-Level Light Therapy; Mice; Nociception; Optogenetics; Pain

2016
Identification of Early RET+ Deep Dorsal Spinal Cord Interneurons in Gating Pain.
    Neuron, 2016, Sep-07, Volume: 91, Issue:5

    The gate control theory (GCT) of pain proposes that pain- and touch-sensing neurons antagonize each other through spinal cord dorsal horn (DH) gating neurons. However, the exact neural circuits underlying the GCT remain largely elusive. Here, we identified a new population of deep layer DH (dDH) inhibitory interneurons that express the receptor tyrosine kinase Ret neonatally. These early RET+ dDH neurons receive excitatory as well as polysynaptic inhibitory inputs from touch- and/or pain-sensing afferents. In addition, they negatively regulate DH pain and touch pathways through both pre- and postsynaptic inhibition. Finally, specific ablation of early RET+ dDH neurons increases basal and chronic pain, whereas their acute activation reduces basal pain perception and relieves inflammatory and neuropathic pain. Taken together, our findings uncover a novel spinal circuit that mediates crosstalk between touch and pain pathways and suggest that some early RET+ dDH neurons could function as pain "gating" neurons.

    Topics: Animals; Clozapine; Female; Interneurons; Male; Mice; Mice, Transgenic; Neural Inhibition; Neurons; Pain; Pain Measurement; Proto-Oncogene Proteins c-ret; Spinal Cord; Spinal Cord Dorsal Horn; Touch

2016